1. Basophils and mast cells and their importance in immune responses

2. Mast cells  Mucosal mast cells - in the mucous membranes of respiratory and gastrointestinal tract, produce histamine, serotonin, heparin, tryptase, leukotriene C4..., participate in parasitosis and allergy  Connective tissue mast cells - the connective tissue, producing tryptase, chymase, prostaglandinD2..., are multiplicated in fibrosis, in parasitosis and allergy are not participating

3. Mast cell functions  Defense against parasitic infections  In pathological circumstances, responsible for the early type of hypersensitivity (immunopathological reaction typeI)  Apply during inflammation, in angiogenesis, in tissue remodeling

4. Mast cell activation Mast cells can be stimulated to degranulate by:  cross-linking of IgE Fc receptors  by anafylatoxins (C3a, C4a, C5a)  direct injury, alcohol, some antibiotics

5. Mast cell activation by cross-linking of IgE Fc receptors  Establishing of multivalent antigen (multicellular parasite) to IgE on highaffinnity Fc receptor for IgE (Fc  RI) to IgE on highaffinnity Fc receptor for IgE (Fc  RI)  Aggregation of several molecules Fc  RI  Initiate mast cell degranulation (cytoplasmic granules mergers with the surface membrane and release their contents)  Activation of arachidonic acid metabolism (leukotriene C4, prostaglandin D2)  Start of production of cytokines (TNF, TGF , IL-4, 5,6...)

6. Mast cell activation scheme

7. Secretory products of mast cells  Cytoplasmatic granules: hydrolytic enzymes, proteoglycans (heparin, chondroitin sulphate), biogenic amines (histamine, serotonin) Histamine causes vasodilation, increased vascular permeability, erythema, edema, itching, contraction of bronchial smooth muscle, increases intestinal peristalsis, increased mucus secretion of mucosal glands in the respiratory tract and GIT (helps eliminate the parasite)  Arachidonic acid metabolites (leukotriene C4, prostaglandin D2)  Cytokines (TNF, TGF , IL-4, 5,6...)

8. The role of mast cells in development of allergy

9. Basophils  Differentiate from myeloid precursor  They are considered to be the circulating form of mast  Receptor equipment, containing granules, the mechanisms of stimulation and functions are very similar to mast cells  They are responsible for the emergence of anaphylactic shock  Basophil activation markers: CD 63, (CD 203)

10. Immune mechanisms of inflammation (Local and systemic reactions)

11. Inflammation Inflammation Is a summary of physiological responses to breach the integrity of the organism, leading to protection against infection of damaged sites, localization of damage and healing. * Is a summary of physiological responses to breach the integrity of the organism, leading to protection against infection of damaged sites, localization of damage and healing. * The first signals to the development of inflammatory responses come from mast cells, phagocytes, and the substances released from damaged cells and extracellular components of matter. * The first signals to the development of inflammatory responses come from mast cells, phagocytes, and the substances released from damaged cells and extracellular components of matter.

12. Local body's response to inflammation Manifestationspain (dolor), fever (calor), redness (rubor), swelling (tumor) and loss of function (funkcio laesa) Local body's response to inflammation Manifestations - pain (dolor), fever (calor), redness (rubor), swelling (tumor) and loss of function (funkcio laesa)

14. Local inflammation increased permeability of blood vessels (vasoactive amines, complement components C3a, C5a, leukotrienes..., swelling at site of inflammation) - increased expression of adhesion molecules on endothelia - activation of coagulation, fibrinolytic, kinin and complement system - influence of local nerve endings (prostaglandins, pain) - changes in temperature (IL-1, IL-6, TNF, prostaglandins) Local inflammation - increased permeability of blood vessels (vasoactive amines, complement components C3a, C5a, leukotrienes..., swelling at site of inflammation) - increased expression of adhesion molecules on endothelia - activation of coagulation, fibrinolytic, kinin and complement system - influence of local nerve endings (prostaglandins, pain) - changes in temperature (IL-1, IL-6, TNF, prostaglandins)

15. Systemic response to inflammation - depends on the extent of damage and duration of local inflammation - fever (proinflammatory cytokines TNF, IL-1, IFN  stimulate hypothalamic center of thermoregulation) - mobilization of tissue metabolism - induction of expression of Hsp (heat-shock-proteins; function as chaperones) - production of acute phase proteins (CRP, SAP, C3, C4; opsonization and complement activation) by liver after stimulation with cytokines (TNF-α, IL-1, IL-6)

16. increased hepatic synthesis of certain serum transport proteins (ceruloplasmin, transferrin) - increased hepatic synthesis of certain serum transport proteins (ceruloplasmin, transferrin) - increased synthesis of protease inhibitors (  macroglobulin) - increased synthesis of protease inhibitors (  macroglobulin) - leukocytosis Septic shock - the massive penetration of microorganisms into the bloodstream (TNF) Anaphylactic shock - basophil degranulation and complement activation with allergen (histamine) - leukocytosis Septic shock - the massive penetration of microorganisms into the bloodstream (TNF) Anaphylactic shock - basophil degranulation and complement activation with allergen (histamine)

17. Repair of damaged tissue - elimination of damaged cells with phagocytes - activation of fibroplastic mechanisms - activation of angiogenesis - regeneration and tissue remodeling

18. Physiological mechanisms of regulation of the immune system

19. Regulation by antigen  Induce immune responses and extinction  Affinity maturation of B lymphocytes  Maintaining immunological memory  Antigenic competition  Threshold density of the complex MHC II-gp Ag on APC

20. Regulation by antibodies  Antibodies competes with the BCR for antigen (negative regulator of B lymphocyte stimulating)  IgG immune complexes bind to the BCR and Fc  R on B cells, resulting in blocking activation of B lymphocytes  Regulation via idiotypic network

21. Regulation by cytokines and cellular contact  Interaction APC - T lymphocyte  Interaction T H 1 – macrophages  Interaction T H 2 - B lymphocytes  Mutual regulation of activity T H 1 versus T H 2  Development of leukocyte subpopulations Negative regulation of effector cells:  CTLA-4 - T cell inhibitory receptor, binds ligands CD80 and CD86  Inhibitory receptors of NK cells  Self-destruction interaction of the apoptotic receptor Fas with ligand FasL on the surface of activated T lymphocytes

22. Interaction of APC with T lymphocyte Interaction of APC with T lymphocyte T cell: TCR - antigen-specific receptor (signal 1) CD4 or CD8 - coreceptor (MHCgp binding) CD 28 - costimulatory receptor (signal 2, binds CD 80, CD 86) CTLA-4 - inhibitory receptor (binds CD 80, CD 86) CD-40L APC: MHC gp I + antigenic peptide MHC gp II + antigenic peptide CD 80, CD 86 - costimulatory ligands CD 40 T cell: TCR - antigen-specific receptor (signal 1) CD4 or CD8 - coreceptor (MHCgp binding) CD 28 - costimulatory receptor (signal 2, binds CD 80, CD 86) CTLA-4 - inhibitory receptor (binds CD 80, CD 86) CD-40L APC: MHC gp I + antigenic peptide MHC gp II + antigenic peptide CD 80, CD 86 - costimulatory ligands CD 40

26. Suppression mediated by T lymphocytes  Mutual negative interaction T H 1 and T H 2 cytokine-mediated (T H 2 lymphocytes produce IL-4 and IL-10 that suppress the immune response based on TH1 cells)  Clonal elimination or anergy of T lymphocytes after contact with antigen on the surface of other cells than APC (lacking costimulating signals)  Regulatory T cells (T r 1 CD 4 + ) help to maintain tolerance to autoantigens

27. Factors influencing the outcome of the immune response The same antigen can induce an active immune response or an active state of tolerance, the result of response depends on many factors: The same antigen can induce an active immune response or an active state of tolerance, the result of response depends on many factors:  State of the immune system  Properties of antigen  Dose of antigen  Route of antigen administration

28. Cytokines (Tissue hormones)

29. Cytokines  Regulatory proteins and glycoproteins produced by leukocytes and other cells  Essential regulators of the immune system  Apply also outside the immune system (angiogenesis, tissue regeneration, carcinogenesis, treatment of many brain functions, embryonic development...)  Cytokines - secreted - membrane (CD 80, CD86, CD40L, FasL..)

30.  Pleiotropic effect  Operates in a cascade  Cytokine Network  Cytokine system is redundant  Effects of cytokines- autocrine - paracrine - endocrine  Are known as interleukins (exception: TNF, lymphotoxin, TGF, interferons, CSF and growth factors)

31. B cells communicate via cytokines with other inflammatory cells, such as T cells and macrophages

32. Distribution of cytokines according their function  Proinflammatory cytokines (IL-1, IL-6,IL- 8,IL- 12,IL- 18, TNF)  Antiinflammatory cytokines (IL-1Ra, IL-4, IL-10, TGF  )  Cytokines with the activity of hematopoietic cells growth factor (IL-2, 3, 4, 5, 6, 7, 9, 11, 14, 15, CSF, SCF, LIF, EPO)  Cytokines applying in T H 2 humoral immunity (IL-4, 5, 9, 13)  Cytokines applying in the cell-mediated immunity T H 1 (IL-2, 12, IFN , GM-CSF, lymphotoxin)  Cytokines with anti-virus effect (IFN- , IFN-  , IFN-  )

33. Cytokine receptors  Consisting of 2 or 3 subunits  One subunit binds cytokine, other are associated with cytoplasmic signaling molecules (protein kinases)  Signaling subunit is shared by several different cytokine receptors - called receptor family  Signaling through these receptors may lead to proliferation, differentiation, activation of effector mechanisms or blocking the cell cycle and induction of apoptosis

34. HLA system (MHC glycoproteins)

35. MHC glycoproteins class I (Major histocompatibility complex)  The function of MHCgpI is presentation of peptide fragments from inside the cell (which are produced by cell, including viral peptides if are present) on the cell surface to T lymphocytes (cytotoxic CD8+)  Present on all nuclear cells of the organism  3 isotypes of classical human MHC gp. (HLA - A,-B,-C)  3 isotypes of nonclassical MHC gp. (HLA - E,-F,-G; molecule CD1)

36. Structure of MHC gp I  MHC gp class I consists of transmembrane chain  and non-covalently associated  2 mikroglobulin   chain has 3 domains, 2 N-terminal (  1,  2 - binding site for peptides) and 1 C-terminal domain (  3 - anchored in the cytoplasmic membrane, a structure similar to imunoglobulin domain)  Binding of peptide is necessary for a stable conformation of MHCgp and thus ensure its long presentation on the cell surface

37. Peptides binding to MHCgpI  MHC gp I bind peptides with a length of 8 to 10 aminoacides  Certain MHC gp molecule binds peptides sharing common structural features - coupling motif (critical are aminoacides near the end of peptide)  The binding of endogenous peptides occurs in the endoplasmic reticulum during biosynthesis of MHC gp

38.  After a string  and  2 mikroglobulin create in the ER, folding into the correct conformation and the mutual association and the association of an appropriate peptide, the complex is further processed in the Golgi apparatus and then is presented on the cell surface  Linked peptides derived from proteins degraded proteasome, which cleaves cytoplasmic proteins for destruction (labeled with ubiquitin), peptide fragments are transported into the ER by specific membrane pump Peptides binding to MHCgpI

41. Non-classical MHC gp I  HLA - E,-F,-G; CD1 molecules  Structurally similar to classical MHC gp  Are less polymorphic  There are only on some cells  They specialize in binding of specific ligands

42.  HLA-E and HLA-G - occurs on the trophoblast cells  Complexes of HLA-E and HLA-G with peptides are recognized by inhibiting receptors of NK cells and contribute to the tolerance of the fetus in utero  CD1 molecules - bind glycolipids (recognized by NK-T lymphocytes)

43. MHC glycoproteins class II  The function of MHC gpII is the presentation of peptide fragments from protein whitch were engulfed by antigen presenting cell on the cell surface to T lymphocytes (auxiliary CD4)  Occur on the APC (dendritic cells, monocytes, macrophages, B lymphocytes)  3 isotypes of MHC gpII (DR, DQ, DP)

44. Structure of MHC gp II  MHC gp II consist of 2 non-covalently associated transmembrane subunits  and   The peptide binding site consists of N-terminal domains  1 and  1  Binding of peptide is necessary for a stable MHC gp conformation and thus ensure its long presentation on the cell surface

45. Binding of peptides to MHC gp II  MHC gpII bind peptides with a length of 15 to 35 aminoacides (but possibly longer - because the peptide binding site is open at both ends)  Certain MHC gp molecule binds peptides sharing common structural features - coupling motif

46.  After a string  and  are created in ER, fold into the correct conformation and the mutual associated are connected with another transmembrane chain called invariant chain, which blocks the binding site for the peptide, this complex is further processed in the Golgi apparatus, secretory vesicles isolated from GA merge with endosomes, then split the invariant chain and peptide fragments from cell absorbed proteins bind into binding site of MHC gp and the complex is then presented on cell surface Binding of peptides to MHC gp II

47. Peptides binding to MHC gp II

48. HLA system – genetic background  HLA complex is localized on chromosome 6  Codominant inheritance of HLA ( Individual has 3 cell surface isotypes of HLA molecules (HLA-A,-B,-C) mostly in 2 different alelic forms )

49.  For MHC gp is typical high polymorphism (except the non-classical MHC gp)  Polymorphism has a protective significance at individual and population level  Ppolymorphism MHC gp causes complications in transplantation Polymorphism of MHC glycoproteins

50. Carry out during the testing before transplantation and in determination of paternity Carry out during the testing before transplantation and in determination of paternity

51. HLA typing 1) Serotyping - Microlymfocytotoxic test Allospecific (typing) serums (obtained from multiple natal to 6 weeks after birth, or commercially prepared sets of typing serums (monoclonal antibodies)) Principle -the incubation of lymphocytes with typing serums in the presence of rabbit complement, then is added the vital dye which stained dead cells -cells carrying a specific HLA are killed by cytotoxic Ab against the Ag - the percentage of dead cells is a measure of serum toxicity (forces and antileukocyte antibody titre) Positive reaction is considered more than 10% dead cells (serological typing can be done also by flow cytometry)

52. 2) Molecular genetic methods 2a) PCR-SSP = Polymerase chain reaction with sequential specific primers  Extracted DNA is used as a substrate in a set of PCR reactions  Each PCR reaction contains primers pair specific for a certain allele (or group of alleles)  Positive and negative reactions are evaluated by electrophoresis, each combination of alleles has a specific electrophoretic painting

53. 2b) PCR-SSO  PCR reaction with sequence-specific oligonucleotides  Multiplication of hypervariable sections of genes coding HLA  Hybridization with enzyme-labeled or radiolabeled DNA probes specific for individual alleles

54. 2c) PCR-SBT (Sequence based typing) The most accurate method of HLA typing. The most accurate method of HLA typing. We get the exact sequence of nucleotides, which compares with a database of known sequences of HLA allels We get the exact sequence of nucleotides, which compares with a database of known sequences of HLA allels

55. THANK YOU FOR YOUR ATTENTION